Free US stock correlation to major indices and sector benchmarks for performance attribution analysis and return source identification. We help you understand how your portfolio moves relative to broader market benchmarks and identify return drivers. We provide correlation analysis, attribution breakdown, and benchmark comparison for comprehensive coverage. Understand performance drivers with our comprehensive correlation and attribution analysis tools for portfolio optimization.
As of April 16, 2026, The Oncology Institute Inc. (TOI) is trading at $3.54, posting an intraday gain of 3.21% during regular market hours. This analysis examines key technical price levels for TOI, recent market context for the specialty oncology care sector, and potential short-term price scenarios that market participants may monitor. No recently released quarterly earnings data is available for TOI at the time of writing, so current price action is largely being driven by technical flows and
The (TOI) Stock: Valuation Metrics (+3.21%) 2026-04-16 - Community Risk Signals
TOI - Stock Analysis
3493 Comments
1370 Likes
1
Ahmoni
Trusted Reader
2 hours ago
If only I had seen it earlier today.
👍 161
Reply
2
Jadia
Insight Reader
5 hours ago
Indices are consolidating after reaching short-term overbought conditions.
👍 194
Reply
3
Lidiana
Returning User
1 day ago
Consolidation phases indicate investors are waiting for catalysts.
👍 163
Reply
4
Leoanthony
Engaged Reader
1 day ago
I understood emotionally, not intellectually.
👍 256
Reply
5
Avika
New Visitor
2 days ago
Join a professional US stock community offering free analysis, daily updates, and strategic insights to help investors make confident and informed decisions. Our community connects thousands of investors who share a common goal of achieving financial independence through smart stock selection.
👍 69
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.